Company profile
AlphaThera
Simple, fast, site-specific antibody conjugation
- Industry
- Biotechnology Research
- Employees
- 13
- Headquarters
- Philadelphia, Pennsylvania
- Founded
- 2016
- LinkedIn followers
- 1,594
- Office locations
- 1
AlphaThera company summary
AlphaThera is a company in the Biotechnology Research industry, headquartered in Philadelphia, Pennsylvania, founded in 2016. On LinkedIn the company has around 13 employees and 1,594 followers. Its listed specialties include Antibody Conjugations, Site-Specific Conjugations, Rapid Conjugations, oYo-Link, Fluorescent Labels.
What technology does AlphaThera use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About AlphaThera
AlphaThera is a US based biotechnology company specializing in antibody labeling reagents. The company developed a unique, site-specific bioconjugation method that enhances assay performance over competing labeling methods. The company was founded by Dr Andrew Tsourkas and Dr. James Hui at the University of Pennsylvania in 2016. They developed the technology of LASIC (Light Assisted Site-specific Conjugation), which led to the creation of oYo-Link® antibody labeling reagents. oYo-Link® reagents enable rapid, covalent, site-specific antibody labeling to a wide range of cargos (e.g. biotin, azide, oligos, fluorescent proteins and more) in just 2 steps - mix and illuminate. Conjugation requires less than 30 seconds hands-on time, and is complete in 2 hours. Unlike other labeling technologies available commercially, no antibody purification is required, as oYo-Link is compatible with all common buffers, including those containing BSA, Tris and Azide, so researchers save valuable time and materials. Furthermore, oYo-Link enables conjugation with as little as 1µg of antibody at concentrations as low as 50µg/mL. AlphaThera's also provides Conjugation Services to researchers that would prefer to outsource their antibody conjugation. AlphaThera’s mission is to remove the complexity and inconsistency that has long been associated with antibody conjugations, making labeling simple, fast and site-specific.
Specialties
Where is AlphaThera located?
AlphaThera lists 1 location.
Compare companies similar to AlphaThera
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
AlphaThera alphathera.com | Biotechnology Research | 13 | 2016 | Philadelphia, Pennsylvania |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about AlphaThera
What does AlphaThera do?
AlphaThera is a US based biotechnology company specializing in antibody labeling reagents. The company developed a unique, site-specific bioconjugation method that enhances assay performance over competing labeling methods. The company was founded by Dr Andrew Tsourkas and Dr. James Hui at the University of Pennsylvania in 2016. They developed the technology of LASIC (Light Assisted Site-specific Conjugation), which led to the creation of oYo-Link® antibody labeling reagents. oYo-Link® reagents enable rapid, covalent, site-specific antibody labeling to a wide range of cargos (e.g. biotin, azide, oligos, fluorescent proteins and more) in just 2 steps - mix and illuminate. Conjugation requires less than 30 seconds hands-on time, and is complete in 2 hours. Unlike other labeling technologies available commercially, no antibody purification is required, as oYo-Link is compatible with all common buffers, including those containing BSA, Tris and Azide, so researchers save valuable time and materials. Furthermore, oYo-Link enables conjugation with as little as 1µg of antibody at concentrations as low as 50µg/mL. AlphaThera's also provides Conjugation Services to researchers that would prefer to outsource their antibody conjugation. AlphaThera’s mission is to remove the complexity and inconsistency that has long been associated with antibody conjugations, making labeling simple, fast and site-specific.
How many employees does AlphaThera have?
AlphaThera has around 13 employees on LinkedIn.
Where is AlphaThera headquartered?
AlphaThera is headquartered in Philadelphia, Pennsylvania.
When was AlphaThera founded?
AlphaThera was founded in 2016.
Build a lead list from companies like AlphaThera
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.